My ePortfolio Register   

Role of histologic regression in melanoma

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.05.17
Views: 361

Dr Simone Ribero - Università degli Studi di Torino, Turin, Italy

Dr Ribero speaks with ecancer at EADO 2017 about the prognostic and diagnostic value of histologic regression in predicting and tracking immune response to skin cancers.

He notes improved tumour infiltration by patients with regressed melanoma, and considers how this may guide immunotherapy treatments in the future.

Dr Ribero also raises discussion about the role of nevi in regression.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence